| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.
|
J Pain
|
2009
|
9.36
|
|
2
|
Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects.
|
Proc Natl Acad Sci U S A
|
2011
|
1.39
|
|
3
|
Genetic dissociation of opiate tolerance and physical dependence in delta-opioid receptor-1 and preproenkephalin knock-out mice.
|
J Neurosci
|
2002
|
1.37
|
|
4
|
Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions.
|
Proc Natl Acad Sci U S A
|
2009
|
1.35
|
|
5
|
Functional analysis of MOR-1 splice variants of the mouse mu opioid receptor gene Oprm.
|
Synapse
|
2004
|
1.27
|
|
6
|
Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing.
|
Mol Pharmacol
|
2005
|
1.20
|
|
7
|
Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding.
|
Mol Pharmacol
|
2010
|
1.15
|
|
8
|
Identification of three new alternatively spliced variants of the rat mu opioid receptor gene: dissociation of affinity and efficacy.
|
J Neurochem
|
2004
|
1.12
|
|
9
|
Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1X.
|
Biochem Biophys Res Commun
|
2003
|
1.11
|
|
10
|
Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes.
|
J Pharmacol Exp Ther
|
2002
|
1.10
|
|
11
|
Sigma1 receptor modulation of opioid analgesia in the mouse.
|
J Pharmacol Exp Ther
|
2002
|
1.09
|
|
12
|
Historical review: Opioid receptors.
|
Trends Pharmacol Sci
|
2003
|
1.07
|
|
13
|
Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene.
|
J Neurochem
|
2008
|
1.07
|
|
14
|
Generation of novel radiolabeled opiates through site-selective iodination.
|
Bioorg Med Chem Lett
|
2011
|
1.02
|
|
15
|
Dimerization of morphine and orphanin FQ/nociceptin receptors: generation of a novel opioid receptor subtype.
|
Biochem Biophys Res Commun
|
2002
|
1.01
|
|
16
|
Synthesis and evaluation of aryl-naloxamide opiate analgesics targeting truncated exon 11-associated μ opioid receptor (MOR-1) splice variants.
|
J Med Chem
|
2012
|
1.00
|
|
17
|
Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action.
|
J Biol Chem
|
2013
|
0.99
|
|
18
|
Modulation of brainstem opiate analgesia in the rat by sigma 1 receptors: a microinjection study.
|
J Pharmacol Exp Ther
|
2007
|
0.96
|
|
19
|
Identification and characterization of seven new exon 11-associated splice variants of the rat μ opioid receptor gene, OPRM1.
|
Mol Pain
|
2011
|
0.95
|
|
20
|
High-affinity mu opioid receptor ligands discovered by the screening of an exhaustively stereodiversified library of 1,5-enediols.
|
J Am Chem Soc
|
2002
|
0.92
|
|
21
|
Mechanistic insights into the allosteric modulation of opioid receptors by sodium ions.
|
Biochemistry
|
2014
|
0.91
|
|
22
|
Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy.
|
J Pharmacol Exp Ther
|
2003
|
0.90
|
|
23
|
Mediation of opioid analgesia by a truncated 6-transmembrane GPCR.
|
J Clin Invest
|
2015
|
0.88
|
|
24
|
14-Methoxymetopon, a very potent mu-opioid receptor-selective analgesic with an unusual pharmacological profile.
|
Eur J Pharmacol
|
2003
|
0.88
|
|
25
|
Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
|
J Pharmacol Exp Ther
|
2003
|
0.87
|
|
26
|
Selective potentiation of opioid analgesia by nonsteroidal anti-inflammatory drugs.
|
Brain Res
|
2005
|
0.87
|
|
27
|
Immunohistochemical labeling of the mu opioid receptor carboxy terminal splice variant mMOR-1B4 in the mouse central nervous system.
|
Brain Res
|
2006
|
0.86
|
|
28
|
The peripheral-type benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line.
|
Biochemistry
|
2005
|
0.86
|
|
29
|
The synergistic analgesic interactions between hydrocodone and ibuprofen.
|
Anesth Analg
|
2003
|
0.85
|
|
30
|
Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P.
|
Synapse
|
2014
|
0.85
|
|
31
|
Feeding induced by food deprivation is differentially reduced by G-protein alpha-subunit antisense probes in rats.
|
Brain Res
|
2002
|
0.85
|
|
32
|
Dynorphin A(1-17)-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
|
J Pharmacol Exp Ther
|
2002
|
0.83
|
|
33
|
Pharmacological characterization of dihydromorphine, 6-acetyldihydromorphine and dihydroheroin analgesia and their differentiation from morphine.
|
Eur J Pharmacol
|
2004
|
0.83
|
|
34
|
Novel 6β-acylaminomorphinans with analgesic activity.
|
Eur J Med Chem
|
2013
|
0.82
|
|
35
|
Morphine regulates expression of μ-opioid receptor MOR-1A, an intron-retention carboxyl terminal splice variant of the μ-opioid receptor (OPRM1) gene via miR-103/miR-107.
|
Mol Pharmacol
|
2013
|
0.81
|
|
36
|
Analgesic synergy between topical morphine and butamben in mice.
|
Anesth Analg
|
2003
|
0.81
|
|
37
|
The role of multidrug resistance-associated protein in the blood-brain barrier and opioid analgesia.
|
Synapse
|
2013
|
0.81
|
|
38
|
Methadone-induced hypoglycemia.
|
Cell Mol Neurobiol
|
2013
|
0.81
|
|
39
|
Opposing actions of neuronal nitric oxide synthase isoforms in formalin-induced pain in mice.
|
Brain Res
|
2009
|
0.80
|
|
40
|
Differential sensitivities of mouse strains to morphine and [Dmt1]DALDA analgesia.
|
Brain Res
|
2003
|
0.80
|
|
41
|
Inhibition of tumor cell growth by Sigma1 ligand mediated translational repression.
|
Biochem Biophys Res Commun
|
2012
|
0.80
|
|
42
|
Affinity labeling mu opioid receptors with novel radioligands.
|
Cell Mol Neurobiol
|
2005
|
0.79
|
|
43
|
Topical methadone and meperidine analgesic synergy in the mouse.
|
Eur J Pharmacol
|
2010
|
0.79
|
|
44
|
Separation of binding affinity and intrinsic activity of the potent mu-opioid 14-methoxymetopon.
|
J Pharmacol Exp Ther
|
2006
|
0.79
|
|
45
|
Sequential cytoprotective responses to Sigma1 ligand-induced endoplasmic reticulum stress.
|
Mol Pharmacol
|
2013
|
0.79
|
|
46
|
Systemically and topically active antinociceptive neurotensin compounds.
|
J Pharmacol Exp Ther
|
2010
|
0.78
|
|
47
|
Three-component coupling approach for the synthesis of diverse heterocycles utilizing reactive nitrilium trapping.
|
Org Lett
|
2014
|
0.77
|
|
48
|
Sandmeyer reaction repurposed for the site-selective, non-oxidizing radioiodination of fully-deprotected peptides: studies on the endogenous opioid peptide α-neoendorphin.
|
Bioorg Med Chem Lett
|
2013
|
0.77
|
|
49
|
Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine.
|
J Clin Invest
|
2017
|
0.77
|
|
50
|
Characterization of rat prepro-orphanin FQ/nociceptin((154-181)): nociceptive processing in supraspinal sites.
|
J Pharmacol Exp Ther
|
2002
|
0.77
|
|
51
|
Feeling pain? Who's your daddy....
|
Nat Med
|
2006
|
0.76
|
|
52
|
Changes in mouse mu opioid receptor Exon 7/8-like immunoreactivity following food restriction and food deprivation in rats.
|
Synapse
|
2009
|
0.76
|
|
53
|
2,6-Dimethyltyrosine analogues of a stereodiversified ligand library: highly potent, selective, non-peptidic mu opioid receptor agonists.
|
J Med Chem
|
2003
|
0.75
|
|
54
|
Codeine and 6-acetylcodeine analgesia in mice.
|
Cell Mol Neurobiol
|
2006
|
0.75
|
|
55
|
Radioligand Binding Assay for an Exon 11-Associated Mu Opioid Receptor Target.
|
Methods Mol Biol
|
2015
|
0.75
|
|
56
|
Pharmacological characterization of beta-endorphin- and dynorphin A(1-17)-induced feeding using G-protein alpha-subunit antisense probes in rats.
|
Peptides
|
2002
|
0.75
|
|
57
|
Truncated μ-Opioid Receptors With 6 Transmembrane Domains Are Essential for Opioid Analgesia.
|
Anesth Analg
|
2017
|
0.75
|